North America Drug Discovery Market Forecast 2022-2030

Publisher Name :
Date: 11-Apr-2022
No. of pages: 162

KEY FINDINGS

The North America drug discovery market is estimated to register a CAGR of 6.14% during the forecast period, 2022-2030. The surging demands are accredited to the growing prioritization of several therapeutic areas like rare diseases and women's health.

REGIONAL INSIGHTS

The United States and Canada are assessed for the North America drug discovery market growth analysis. In Canada, the drug discovery and development market is comparatively small but is projecting gradual growth in terms of relevance and developments at multiple levels. For instance, Sunshine Biopharma, a pharmaceutical company in Canada, is engaged in the research, development, and commercialization of antiviral and oncology drugs.

Also, several Canadian-based biotechnology companies' and academic institutions' inventions and concepts have facilitated the development of essential drug delivery products that have improved the landscape of drug therapy in treating cancer and infectious diseases. Additionally, through partnerships, pharmaceutical companies' extensive R&D activities enable additional investments in small and medium-sized enterprises (SMEs) and venture funds. Besides, pharmaceutical sales in Canada doubled between 2001 and 2015, with hospitals and retail sales representing 12.5% and 87.5% of the total pharmaceutical sales, respectively. Such developments contribute to market growth.

COMPETITIVE INSIGHTS

Some of the leading companies in the market are Icon Plc, Merck & Co Inc, Johnson & Johnson, IQVIA Holdings Inc, etc.

Our report offerings include:

- Explore key findings of the overall market

- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

- Market Segmentation cater to a thorough assessment of key segments with their market estimations

- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

North America Drug Discovery Market Forecast 2022-2030

Table Of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing R&D For Tackling Several Diseases
3.1.2. Technological Advancements
3.2. Key Restraints
3.2.1. Extensive Time-Consuming Process
3.2.2. Highly Regulated Market
3.2.3. Project Feasibility And Success Rate
4. Key Analytics
4.1. Impact Of Covid-19 On Drug Discovery Market
4.2. Key Market Trends
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Drug Discovery And Development Process
4.5.1. Drug Discovery And Development
4.5.2. Preclinical Research
4.5.3. Clinical Research
4.5.4. Regulatory Authority Review
4.5.5. Post Market Safety Monitoring
4.6. Regulatory Framework
5. Market By Drug Type
5.1. Small Molecule Drug
5.2. Biologic Drug
6. Market By Service
6.1. Chemical Services
6.2. Drug Metabolism And Pharmacokinetics Services
6.3. Biological Services
6.4. Other Pharmaceutical Services
7. Market By End-User
7.1. Pharmaceutical Companies
7.2. Contract Research Organizations
7.3. Research Institutes
7.4. Other End-Users
8. Market By Technology
8.1. High Throughput Screening
8.2. Spectroscopy
8.3. Combinatorial Chemistry
8.4. Biochips
8.5. Pharmacogenomics And Pharmacogenetics
8.6. Bioinformatics
8.7. Metabolomics
8.8. Nanotechnology
8.9. Other Technologies
9. Geographical Analysis
9.1. North America
9.1.1. Market Size & Estimates
9.1.2. Key Growth Enablers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. United States
9.1.5.2. Canada
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. Agilent Technologies Inc
10.2.2. Astrazeneca Plc
10.2.3. Bayer Ag
10.2.4. Charles River Laboratories International Inc
10.2.5. Eli Lilly And Company
10.2.6. Evotec Se
10.2.7. Glaxosmithkline Plc
10.2.8. Icon Plc
10.2.9. Iqvia Holdings Inc
10.2.10. Johnson & Johnson
10.2.11. Merck & Co Inc
10.2.12. Novartis Ag
10.2.13. Pfizer Inc
10.2.14. Roche Ag

List Of Tables
Table 1: Market Snapshot - North America Drug Discovery
Table 2: Regulatory Framework
Table 3: North America Drug Discovery Market, By Drug Type, Historical Years, 2018-2021 (In $ Million)
Table 4: North America Drug Discovery Market, By Drug Type, Forecast Years, 2022-2030 (In $ Million)
Table 5: North America Drug Discovery Market, By Service, Historical Years, 2018-2021 (In $ Million)
Table 6: North America Drug Discovery Market, By Service, Forecast Years, 2022-2030 (In $ Million)
Table 7: North America Drug Discovery Market, By End-User, Historical Years, 2018-2021 (In $ Million)
Table 8: North America Drug Discovery Market, By End-User, Forecast Years, 2022-2030 (In $ Million)
Table 9: North America Drug Discovery Market, By Technology, Historical Years, 2018-2021 (In $ Million)
Table 10: North America Drug Discovery Market, By Technology, Forecast Years, 2022-2030 (In $ Million)
Table 11: North America Drug Discovery Market, By Country, Historical Years, 2018-2021 (In $ Million)
Table 12: North America Drug Discovery Market, By Country, Forecast Years, 2022-2030 (In $ Million)
Table 13: Leading Players Operating In North America Drug Discovery Market
Table 14: List Of Mergers & Acquisitions
Table 15: List Of Product Launches & Developments
Table 16: List Of Partnerships & Agreements
Table 17: List Of Business Expansions & Divestitures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter's Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Drug Discovery And Development Process
Figure 5: North America Drug Discovery Market, Growth Potential, By Drug Type, In 2021
Figure 6: North America Drug Discovery Market, By Small Molecule Drug, 2022-2030 (In $ Million)
Figure 7: North America Drug Discovery Market, By Biologic Drug, 2022-2030 (In $ Million)
Figure 8: North America Drug Discovery Market, Growth Potential, By Service, In 2021
Figure 9: North America Drug Discovery Market, By Chemical Services, 2022-2030 (In $ Million)
Figure 10: North America Drug Discovery Market, By Drug Metabolism And Pharmacokinetics Services, 2022-2030 (In $ Million)
Figure 11: North America Drug Discovery Market, By Biological Services, 2022-2030 (In $ Million)
Figure 12: North America Drug Discovery Market, By Other Pharmaceutical Services, 2022-2030 (In $ Million)
Figure 13: North America Drug Discovery Market, Growth Potential, By End-User, In 2021
Figure 14: North America Drug Discovery Market, By Pharmaceutical Companies, 2022-2030 (In $ Million)
Figure 15: North America Drug Discovery Market, By Contract Research Organizations, 2022-2030 (In $ Million)
Figure 16: North America Drug Discovery Market, By Research Institutes, 2022-2030 (In $ Million)
Figure 17: North America Drug Discovery Market, By Other End-Users, 2022-2030 (In $ Million)
Figure 18: North America Drug Discovery Market, Growth Potential, By Technology, In 2021
Figure 19: North America Drug Discovery Market, By High Throughput Screening, 2022-2030 (In $ Million)
Figure 20: North America Drug Discovery Market, By Spectroscopy, 2022-2030 (In $ Million)
Figure 21: North America Drug Discovery Market, By Combinatorial Chemistry, 2022-2030 (In $ Million)
Figure 22: North America Drug Discovery Market, By Biochips, 2022-2030 (In $ Million)
Figure 23: North America Drug Discovery Market, By Pharmacogenomics And Pharmacogenetics, 2022-2030 (In $ Million)
Figure 24: North America Drug Discovery Market, By Bioinformatics, 2022-2030 (In $ Million)
Figure 25: North America Drug Discovery Market, By Metabolomics, 2022-2030 (In $ Million)
Figure 26: North America Drug Discovery Market, By Nanotechnology, 2022-2030 (In $ Million)
Figure 27: North America Drug Discovery Market, By Other Technologies, 2022-2030 (In $ Million)
Figure 28: North America Drug Discovery Market, Country Outlook, 2021 & 2030 (In %)
Figure 29: United States Drug Discovery Market, 2022-2030 (In $ Million)
Figure 30: Canada Drug Discovery Market, 2022-2030 (In $ Million)
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs